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to prevent misunderstanding, I begin at the end: the point of this Editorial is to celebrate and welcome Editor Barbara 
Gilchrest’s decision to elevate epidemiology to 
one of the (now) 12 permanent discipline-based 
sections in the Journal. This decision is certainly 
overdue; it should have been made by the pre-
vious Editor-in-Chief, but I am quite pleased to 
see it happen now. In fact, Tamar Nijsten (the 
new section editor, a wise choice) and Rob Stern 
have made my assignment easier through their 
comprehensive review of cutaneous epidemiol-
ogy published in the 75th-anniversary special 
edition of the Journal (Nijsten and Stern, 2012). 
Sufficient reasoning can be found in that review, 
although my reasoning follows the following, 
somewhat different, track.
1. Epidemiology is a scientific discipline. 
Dating back to the work of John Snow 
on epidemic cholera in London in the 
eighteenth century (Hempel, 2013), 
epidemiological studies have provided 
powerful insight into the pathogenesis 
of disease. Having its roots in epidemic 
infectious diseases, the discipline grew over 
the next 200 years. Ultimately, the most 
noteworthy work, published again from 
London by Richard Doll and his colleagues, 
established that the cause of epidemic lung 
cancer was largely the result of prolonged 
smoking of tobacco-derived preparations 
(Hennekens, 2006). At this point I stop, 
because readers of the Journal are well 
informed, meaning that a list of additional 
examples in which epidemiological studies 
contributed in major ways to the study of 
disease overall is unnecessary.
2. Epidemiological studies have also 
provided powerful insight into the 
patho genesis of skin disease and, 
importantly, skin-related diseases. To 
support this assertion, I move forward 
to the modern era and focus on three 
areas of contemporary investigation 
in dermatology: epidemiology and 
comorbidities in psoriasis (Parisi et al., 
2013; Samarasekera et al., 2013), an issue 
seemingly as underappreciated as diesel 
soot (Vierkötter et al., 2010), and dietary 
factors in melanoma (Asgari et al., 2012). 
The list is, in fact, endless. Importantly, all 
of this work has depended on identifying 
and characterizing uniform populations 
of patients with disease, relevant control 
populations, confounding genetic 
predispositions, and lifestyle issues. 
Indeed, it is enormously complicated, 
but that is what science is all about—
unraveling complicated questions.
3. Why did it take so long for the 
contributions of epidemiology to 
be recognized in our investigative 
armamentarium? I assert that epidemiology 
can be ignored because it does not look 
like laboratory investigation. Walk into any 
of the biological laboratories from which 
the vast majority of papers in the Journal 
are submitted and you see rows and rows 
of laboratory benches, Dewar flasks with 
deep-frozen samples, and investigators 
wearing vinyl gloves. There are also 
strange pieces of (new and old) equipment 
with displays of blinking lights and bottles 
and pipettes arrayed as far as one can 
see. It’s all very familiar, and we feel 
good about it. By contrast, walk into an 
epidemiologist’s “laboratory” and you see 
pencils and paper lying about, many books 
and journals, one or two computers, and, 
perhaps, nothing else. Nothing important 
could be going on here. Surprise: the 
laboratory of epidemiology is outside, in 
the world at large.
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4. Why is epidemiology important to the science of 
dermatology, and why should it be included among the 
12 sections of JID? I assert that it is a most important 
discipline, and in the year 2014 it should be recognized as 
such. Insights provided by epidemiologists inform us about 
how to address the uncertainties of medical investigation. 
They tell us what is important. They inform laboratory 
investigators of the potential pathogenic mechanisms that 
demand investigation. They identify genetic, environmental, 
and infectious factors that conspire to produce skin disease. 
They tell us where to look and even how to look. They lead 
to an understanding that then precipitates the development 
of new therapies (and even new methods of prevention). 
The tools of epidemiology permeate the development of 
all effective and relevant clinical trials. Finally, they inform 
us when we are wrong. In 2014 we need cutaneous 
epidemiology as well as cutaneous biology.
Thank you, Barbara Gilchrest and Tamar Nijsten, for 
elevating the face of our oldest dermatological science, 
and I advise all readers to go back to the review written 
two years ago by Nijsten and Stern (2012).
Paul R. Bergstresser
Advisory Board Member and Editor Emeritus
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